Use of gelatine capsules for application of methamphetamine: a new harm reduction approach.
Standard
Use of gelatine capsules for application of methamphetamine: a new harm reduction approach. / Mravčík, Viktor; Skařupová, Kateřina; Orlíková, Barbora; Zábranský, Tomáš; Karachaliou, Krystallia; Schulte, Bernd.
in: INT J DRUG POLICY, Jahrgang 22, Nr. 2, 2, 2011, S. 172-173.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Use of gelatine capsules for application of methamphetamine: a new harm reduction approach.
AU - Mravčík, Viktor
AU - Skařupová, Kateřina
AU - Orlíková, Barbora
AU - Zábranský, Tomáš
AU - Karachaliou, Krystallia
AU - Schulte, Bernd
PY - 2011
Y1 - 2011
N2 - In order to reduce injecting drug use, low-threshold facilities in the Czech Republic have started to distribute empty gelatine capsules as an oral alternative of drug application for those injecting methamphetamine. This report reviews implementation of this intervention and its possible benefits and limitations.
AB - In order to reduce injecting drug use, low-threshold facilities in the Czech Republic have started to distribute empty gelatine capsules as an oral alternative of drug application for those injecting methamphetamine. This report reviews implementation of this intervention and its possible benefits and limitations.
KW - Humans
KW - Questionnaires
KW - Czech Republic
KW - Administration, Oral
KW - Focus Groups
KW - Program Evaluation
KW - Injections, Intravenous
KW - Drug Compounding
KW - Amphetamine-Related Disorders/rehabilitation
KW - Capsules
KW - Central Nervous System Stimulants/administration & dosage/adverse effects/chemistry
KW - Chemistry, Pharmaceutical
KW - Excipients/chemistry
KW - Gelatin/chemistry
KW - Harm Reduction
KW - Methamphetamine/administration & dosage/adverse effects/chemistry
KW - Substance Abuse, Intravenous/prevention & control
KW - Humans
KW - Questionnaires
KW - Czech Republic
KW - Administration, Oral
KW - Focus Groups
KW - Program Evaluation
KW - Injections, Intravenous
KW - Drug Compounding
KW - Amphetamine-Related Disorders/rehabilitation
KW - Capsules
KW - Central Nervous System Stimulants/administration & dosage/adverse effects/chemistry
KW - Chemistry, Pharmaceutical
KW - Excipients/chemistry
KW - Gelatin/chemistry
KW - Harm Reduction
KW - Methamphetamine/administration & dosage/adverse effects/chemistry
KW - Substance Abuse, Intravenous/prevention & control
M3 - SCORING: Journal article
VL - 22
SP - 172
EP - 173
JO - INT J DRUG POLICY
JF - INT J DRUG POLICY
SN - 0955-3959
IS - 2
M1 - 2
ER -